Biggest News Aggregation in the World
📰 Risk Evaluation News

Page 13 - Risk Evaluation News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Risk Evaluation. Real-time updates on events, politics, business and more.

Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck

SHANGHAI, Dec. 4, 2023 /PRNewswire/ -- On 4 Dec. 2023, Abbisko Therapeutics announced that it has entered into a licensing agreement with Merck, a leading science and technology company headquartered in Darmstadt, Germany. Under the terms of the agreement, Merck will be granted an exclusive license to commercialize products comprising or containing pimicotinib (ABSK021) for all indications in Chinese...
Hong Kong United States Xu Yao Chang Andrew Paterson Abbisko Therapeutics License Agreement

Report: Abortion pill being prescribe past FDA limits

The abortion pill is likely being prescribed past the approved U.S. Food and Drug Administration’s (FDA) gestational limit of 70 days/10 weeks, which could result in failed abortions, according to the latest abortion surveillance published by the Centers for Disease Control and Prevention (CDC). This seems to confirm that bad actors within the abortion industry are openly flouting the FDA’s approved limit for the chemical abortion pill regimen by prescribing abortion-inducing drugs into the ...
United States Israel General New Jersey New Hampshire Michael New Carole Novielli
Source: wnd.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Bristol Myers Squibb and 2seventy bio Provide Update on U.S. FDA Review of sBLA for Abecma (idecabtagene vicleucel) in Earlier Lines of Therapy for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma

Bristol Myers Squibb and 2seventy bio, Inc. today announced the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee will meet to review data supporting the supplemental...
United States Hemophagocytic Lymphohistiocytosis Bristol Myers Squibb Exchange Commission Oncologic Drugs Advisory Committee American Society Of Hematology

Why Sodium Matters, Especially If You Have Narcolepsy

(BPT) - People with narcolepsy may be unaware that their chronic condition may increase their odds of having a stroke*, heart disease†, hypertension†, diabetes†, and other cardiometabolic comorbidities† compared to
Office Of Orphan Product Development Jazz Pharmaceuticals Drug Administration Central Nervous System P Value Important Safety Information Prescribing Information

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science